Matches in Wikidata for { <http://www.wikidata.org/entity/Q91781303> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91781303 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q91781303 description "scientific article published on 06 August 2019" @default.
- Q91781303 description "wetenschappelijk artikel" @default.
- Q91781303 description "наукова стаття, опублікована 6 серпня 2019" @default.
- Q91781303 name "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 name "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 type Item @default.
- Q91781303 label "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 label "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 prefLabel "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 prefLabel "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 P1433 Q91781303-429A1E2A-D9FC-4B2E-8CF3-5B215B243671 @default.
- Q91781303 P1476 Q91781303-E21CD7E3-21DC-48A3-AC08-C3B2AD213162 @default.
- Q91781303 P2093 Q91781303-5E28358B-AFA0-45A6-BE8C-96D5F2170BBB @default.
- Q91781303 P2093 Q91781303-A688C616-1E5D-40D7-B969-12C963F9EE07 @default.
- Q91781303 P2093 Q91781303-B97AC1D9-F686-4CE3-A4F7-EFB5968499B2 @default.
- Q91781303 P2093 Q91781303-FE17E8CA-30A5-460B-A4B8-8F99313ED8FD @default.
- Q91781303 P304 Q91781303-15BCB09D-3032-4076-B541-6F29A23461E9 @default.
- Q91781303 P31 Q91781303-5AE5BB9C-A520-4D53-91C2-CB54D8519D3B @default.
- Q91781303 P356 Q91781303-AC1A5A93-2100-428D-95DE-2E0CE04A1600 @default.
- Q91781303 P433 Q91781303-2E68BD76-3C94-41E9-A1B2-A007F959F47A @default.
- Q91781303 P478 Q91781303-1945073F-C847-4EC2-83B1-E111856D8479 @default.
- Q91781303 P577 Q91781303-2F797D92-7A24-4D0B-9B4D-72B2D185EBFE @default.
- Q91781303 P698 Q91781303-02C86261-4745-43EC-A8EB-A758FC546556 @default.
- Q91781303 P921 Q91781303-FBAC4ADE-A6C8-403B-870A-6164A1E2AC2D @default.
- Q91781303 P356 ART.40919 @default.
- Q91781303 P698 31058470 @default.
- Q91781303 P1433 Q4797636 @default.
- Q91781303 P1476 "Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series" @default.
- Q91781303 P2093 "Andrew L Mammen" @default.
- Q91781303 P2093 "Eleni Tiniakou" @default.
- Q91781303 P2093 "Erika Rivera" @default.
- Q91781303 P2093 "Lisa Christopher-Stine" @default.
- Q91781303 P304 "1723-1726" @default.
- Q91781303 P31 Q13442814 @default.
- Q91781303 P356 "10.1002/ART.40919" @default.
- Q91781303 P433 "10" @default.
- Q91781303 P478 "71" @default.
- Q91781303 P577 "2019-08-06T00:00:00Z" @default.
- Q91781303 P698 "31058470" @default.
- Q91781303 P921 Q55785927 @default.